Primary Site >> Biliary tract Cancer

Gene >> EGR3

  • 1993
  • 2000
  • 2002
  • 2003
  • 2007
  • 2008
  • 2009
  • 2011
  • 2014
  • 2015
  • 2016
Ref: Duck hepatitis B virus (DHBV) infection in Indian domestic ducks: a pilot study.
PMID: 8109057
Ref: Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma.
PMID: 10827231
Ref: Endoscopic treatment of cholangiocarcinoma and carcinoma of the duodenal papilla by intraductal high-intensity US: Results of a pilot study.
PMID: 12447312
Ref: Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
PMID: 12767091
Ref: Endoscopic bilateral metal stent placement for advanced hilar cholangiocarcinoma: a pilot study of a newly designed Y stent.
PMID: 17643714
Ref: S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study.
PMID: 18214482
Ref: Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
PMID: 18759346
Ref: [A case report of S-1 monotherapy responding to unresectable gallbladder cancer].
PMID: 20037435
Ref: A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro.
PMID: 21529356
Ref: 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study.
PMID: 24448917
Ref: Efficacy of hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic pegylated interferon alpha-2b for advanced intrahepatic cholangiocarcinoma.
PMID: 24817369
Ref: Palliative treatment for advanced biliary adenocarcinomas with combination dimethyl sulfoxide-sodium bicarbonate infusion and S-adenosyl-L-methionine.
PMID: 25102038
Ref: Neoadjuvant Down-Sizing of Hilar Cholangiocarcinoma with Photodynamic Therapy--Long-Term Outcome of a Phase II Pilot Study.
PMID: 26561801
Ref: Radioembolization with (90)Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study.
PMID: 28078110